Korea Investment Corp’s Core Laboratories CLB Stock Holding History

Korea Investment Corp’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-45,300	Closed	-$4.47M	–	656
2017 Q3	$4.47M	Sell	45,300 -8,300	-15%	-$805K	0.02%	467
2017 Q2	$5.43M	Buy	53,600 +10,000	+23%	+$1.08M	0.03%	445
2017 Q1	$5.04M	Sell	43,600 -4,400	-9%	-$511K	0.03%	437
2016 Q4	$5.76M	Sell	48,000 -29,500	-38%	-$3.27M	0.03%	406
2016 Q3	$8.71M	Buy	77,500 +11,600	+18%	+$1.34M	0.05%	337
2016 Q2	$8.16M	Buy	65,900 +13,500	+26%	+$1.63M	0.05%	331
2016 Q1	$5.89M	Buy	52,400 +49,000	+1,441%	+$5.09M	0.04%	336
2015 Q4	$369K	Sell	3,400 -10,600	-76%	-$1.21M	﹤0.01%	623
2015 Q3	$1.4M	Buy	+14,000	New	+$1.52M	0.01%	512
2014 Q2	–	Sell	-4,600	Closed	-$913K	–	563
2014 Q1	$913K	Buy	+4,600	New	+$868K	0.01%	574

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Korea Investment Corp's CLB Position: Q4 2017 in Review

Korea Investment Corp sold out of Core Laboratories (CLB) in Q4 2017, closing a stake of 45,300 shares — an estimated $4.47M sold.

Korea Investment Corp first reported a position in CLB in Q1 2014 and held it in 10 quarters. The position peaked at $8.71M in Q3 2016. 356 funds tracked by Wall St. Rank hold CLB as of Q4 2017.

Korea Investment Corp reported no remaining Core Laboratories position as of Q4 2017 after selling out during the quarter.
Korea Investment Corp sold 45,300 Core Laboratories shares in Q4 2017, an estimated $4.47M.
Korea Investment Corp first reported a position in Core Laboratories in Q1 2014 and held it in 10 quarters.
Korea Investment Corp's Core Laboratories position peaked at $8.71M in Q3 2016.
356 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2017.

Based on Korea Investment Corp's 13F filing for Q4 2017, filed 12 Feb 2018.